Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898)

Inclusion Criteria: * Completed study P06107 and demonstrated acceptable degree of compliance with medication, visits and other study requirements * Must be male or a female who is not of childbearing potential and is not sexually active or is using a medically accepted method of contraception; or female who is not pregnant, or not lactating. * Must have a caregiver or responsible person living with the participant who agrees to provide support to ensure compliance with treatment, visits, and protocol procedures Exclusion Criteria: * Positive pregnancy test or intention to become pregnant during the study * At imminent risk of self-harm or harm to others * Under involuntary inpatient commitment * Known serological evidence of human immunodeficiency virus (HIV) antibody